Bruce I. Sachs

CIK: 0001197036

Transaction Breakdown

Open Market Buys (P)2 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (78.6%)

Compensation grants

Other (G, F, J, C, D, …)1 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VRTX

VERTEX PHARMACEUTICALS INC / MA

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

VRTX
VERTEX PHARMACEUTICALS INC / MA
Oct 15, 2026
Award(A)
Deferred Stock Units
Direct
93 shares at avg. $512.44-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Aug 27, 2026
Gift(G)
Direct
6K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jul 15, 2026
Award(A)
Deferred Stock Units
Direct
100 shares at avg. $475.28-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
2.9K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Apr 15, 2026
Award(A)
Deferred Stock Units
Direct
107 shares at avg. $442.50-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 15, 2026
Award(A)
Deferred Stock Units
Direct
107 shares at avg. $443.56-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Oct 15, 2025
Award(A)
Deferred Stock Units
Direct
116 shares at avg. $410.31-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Aug 6, 2025
Purchase(P)
Direct
1.6K shares at avg. $389.36$636K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Aug 6, 2025
Purchase(P)
Direct
3.4K shares at avg. $389.84$1.3M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jul 15, 2025
Award(A)
Deferred Stock Units
Direct
101 shares at avg. $469.34-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2025
Award(A)
Stock Option (Right to Buy)
Direct
2.4K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Apr 15, 2025
Award(A)
Deferred Stock Units
Direct
95 shares at avg. $497.51-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 15, 2025
Award(A)
Deferred Stock Units
Direct
112 shares at avg. $420.31-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Oct 15, 2024
Award(A)
Deferred Stock Units
Direct
90 shares at avg. $484.39-

		Type	Shares	Price		Ownership
Oct 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	93	$512.44	-	Direct
Aug 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Gift(G)	6,000	-	$0	Direct
Jul 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	100	$475.28	-	Direct
May 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Stock Option (Right to Buy)	2,866	-	-	Direct
Apr 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	107	$442.50	-	Direct
Jan 15, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	107	$443.56	-	Direct
Oct 15, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	116	$410.31	-	Direct
Aug 6, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Purchase(P)	1,634	$389.36	$636,214	Direct
Aug 6, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Purchase(P)	3,366	$389.84	$1,312,201	Direct
Jul 15, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	101	$469.34	-	Direct
May 1, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Stock Option (Right to Buy)	2,398	-	-	Direct
Apr 15, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	95	$497.51	-	Direct
Jan 15, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	112	$420.31	-	Direct
Oct 15, 2024	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A) Deferred Stock Units	90	$484.39	-	Direct

1-14 of 14 transactions

About SACHS BRUCE I

SACHS BRUCE I (SEC CIK 0001197036) files insider reports with the SEC as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 13 ownership filings by SACHS BRUCE I, all Form 4s, filed between Oct 17, 2024 and Oct 19, 2026. Those filings report 14 transactions, from Oct 15, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SACHS BRUCE I's filings is in BOSTON, MA.

Recent filings by SACHS BRUCE I

Oct 15, 2026: Grant or award of VRTX derivative securities (Form 4, code A).
Aug 27, 2026: Gift of VRTX shares (Form 4, code G).
Jul 15, 2026: Grant or award of VRTX derivative securities (Form 4, code A).
May 1, 2026: Grant or award of VRTX derivative securities (Form 4, code A).
Apr 15, 2026: Grant or award of VRTX derivative securities (Form 4, code A).

Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Brennan Daniel J., Director
Garber Alan M, Director
van Grunsven Jasper, EVP, CP and NPPO
Ambrose Kristen, SVP & Chief Accounting Officer
Tatsis Ourania, EVP, Chief Reg. & Quality Off.
Sachdev Amit, EVP Chief Patient & Ext Af Off

How to read Form 4 transaction codes